Michael Tachezy Selected Research

Michael Tachezy Research Topics

Disease

19	Neoplasms (Cancer) 04/2022 - 05/2011
9	Adenocarcinoma 02/2022 - 08/2011
6	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2011
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2012
4	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 07/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019 - 01/2012
3	Carcinogenesis 10/2021 - 08/2011
3	Carcinoma (Carcinomatosis) 06/2021 - 09/2013
3	Anastomotic Leak 06/2021 - 01/2020
2	Neoplasms, Cystic, Mucinous, and Serous 01/2017 - 10/2010
2	Chronic Pancreatitis 01/2017 - 01/2012
2	Atherosclerosis 03/2008 - 07/2007
1	Sepsis (Septicemia) 01/2020
1	Neuroblastoma 08/2016
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 10/2014
1	Colorectal Neoplasms (Colorectal Cancer) 09/2012
1	Lung Diseases (Lung Disease) 01/2012
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 12/2011
1	Primitive Neuroectodermal Tumors (PNET) 10/2011
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2011
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2011
1	Pancreatic Fistula (Pancreatic Fistulas) 05/2011
1	Infarction (Infarctions) 11/2010

Drug/Important Bio-Agent (IBA)

9	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 08/2016 - 10/2011
6	Proteins (Proteins, Gene)FDA Link 03/2020 - 12/2011
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 10/2011
3	Cell Adhesion MoleculesIBA 09/2019 - 01/2014
2	Immunoglobulins (Immunoglobulin)IBA 08/2016 - 12/2011
2	Chemokine ReceptorsIBA 09/2013 - 08/2011
1	Indicators and Reagents (Reagents)IBA 04/2022
1	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 10/2021
1	SelectinsIBA 06/2021
1	Integrin alphaVIBA 06/2021
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	130-nm albumin-bound paclitaxelIBA 09/2016
1	folfirinoxIBA 09/2016
1	Gemcitabine FDA Link 09/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2016
1	Leucovorin (Folinic Acid)FDA Link 09/2016
1	Fluorouracil (Carac)FDA LinkGeneric 09/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2016
1	TenascinIBA 04/2016
1	Tumor Biomarkers (Tumor Markers)IBA 04/2016
1	C-Reactive ProteinIBA 01/2016
1	AlbuminsIBA 01/2016
1	Polysaccharides (Glycans)IBA 12/2014
1	Blood Group Antigens (Blood Groups)IBA 12/2014
1	GlycoconjugatesIBA 12/2014
1	Glycoproteins (Glycoprotein)IBA 12/2014
1	Immunoglobulin M (IgM)IBA 12/2014
1	ABO Blood-Group SystemIBA 12/2014
1	Epithelial Cell Adhesion MoleculeIBA 09/2014
1	Carcinoembryonic AntigenIBA 01/2014
1	Biological ProductsIBA 01/2014
1	Chemokine CXCL12IBA 09/2013
1	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2013
1	Messenger RNA (mRNA)IBA 01/2012
1	Complementary DNA (cDNA)IBA 01/2012
1	MicroRNAs (MicroRNA)IBA 01/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2011
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2011
1	Hormones (Hormone)IBA 10/2011
1	ChemokinesIBA 08/2011
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 05/2011
1	EndoglinIBA 10/2010
1	CholesterolIBA 03/2008
1	Apolipoproteins E (ApoE)IBA 03/2008
1	Ezetimibe (Zetia)FDA Link 03/2008
1	ApolipoproteinsIBA 03/2008
1	maleimideIBA 07/2007
1	trans-sodium crocetinate (crocetin)IBA 07/2007
1	CarbocyaninesIBA 07/2007

Therapy/Procedure

9	Therapeutics 02/2022 - 05/2011
2	Esophagectomy 02/2022 - 06/2021
2	Neoadjuvant Therapy 02/2022 - 06/2014
1	Aftercare (After-Treatment) 06/2021
1	Stents 06/2021
1	Catheters 01/2020
1	Drug Therapy (Chemotherapy) 09/2016
1	Metastasectomy 01/2016
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	Prostatectomy (Retropubic Prostatectomy) 12/2011
1	Pancreatectomy 05/2011
1	Conservative Treatment 11/2010